Abstract |
Cell division cycle phosphatases CDC25 A, B and C are involved in modulating cell cycle processes and are found overexpressed in a large panel of cancer typology. Here, we describe the development of two novel quinone-polycycle series of CDC25A and C inhibitors on the one hand 1a-k, coumarin-based, and on the other 2a-g, quinolinone-based, which inhibit either enzymes up to a sub-micro molar level and at single-digit micro molar concentrations, respectively. When tested in six different cancer cell lines, compound 2c displayed the highest efficacy to arrest cell viability, showing in almost all cell lines sub-micro molar IC50 values, a profile even better than the reference compound NCS95397. To investigate the putative binding mode of the inhibitors and to develop quantitative structure-activity relationships, molecular docking and 3-D QSAR studies were also carried out. Four selected inhibitors, 1a, 1d, 2a and 2c have been also tested in A431 cancer cells; among them, compound 2c was the most potent one leading to cell proliferation arrest and decreased CDC25C protein levels together with its splicing variant. Compound 2c displayed increased phosphorylation levels of histone H3, induction of PARP and caspase 3 cleavage, highlighting its contribution to cell death through pro-apoptotic effects.
|
Authors | Clemens Zwergel, Brigitte Czepukojc, Emilie Evain-Bana, Zhanjie Xu, Giulia Stazi, Mattia Mori, Alexandros Patsilinakos, Antonello Mai, Bruno Botta, Rino Ragno, Denise Bagrel, Gilbert Kirsch, Peter Meiser, Claus Jacob, Mathias Montenarh, Sergio Valente |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 134
Pg. 316-333
(Jul 07 2017)
ISSN: 1768-3254 [Electronic] France |
PMID | 28431339
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Coumarins
- Enzyme Inhibitors
- Quinolones
- CDC25A protein, human
- CDC25C protein, human
- cdc25 Phosphatases
|
Topics |
- Antineoplastic Agents
(chemistry, pharmacology)
- Apoptosis
(drug effects)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Coumarins
(chemistry, pharmacology)
- Enzyme Inhibitors
(chemistry, pharmacology)
- Humans
- Neoplasms
(drug therapy, metabolism)
- Quantitative Structure-Activity Relationship
- Quinolones
(chemistry, pharmacology)
- cdc25 Phosphatases
(antagonists & inhibitors, metabolism)
|